Literature DB >> 3097277

Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma.

C A Hoefnagel, C C Delprat, H R Marcuse, J J de Vijlder.   

Abstract

To evaluate the reliability of total-body scintigraphy using [201Tl]chloride in postoperative follow-up of thyroid carcinoma, this procedure was performed in 326 patients after total thyroidectomy for thyroid carcinoma. The results were compared with those of 131I scintigraphy and thyroglobulin assays. 201Tl total-body scintigraphy was found to have the greatest sensitivity (94%), whereas 131I scintigraphy had the highest specificity (99%). It is shown that 201Tl total-body scintigraphy is a useful procedure in follow-up of thyroid cancer, however, the combination of parameters provides the greatest reliability. In medullary thyroid carcinoma, which is usually 131I negative, 201Tl total-body scintigraphy can be of great value for the localization of metastases which are indicated by elevated serum levels of calcitonin and carcinoembryonic antigen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3097277

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  8 in total

1.  The role of 201Tl scintigraphy in evaluating proliferative activity in thyroid neoplasms.

Authors:  K Nakada; C Katoh; K Kanegae; E Tsukamoto; K Itoh; M Furudate; N Tamaki
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

Review 2.  The role of nuclear medicine in oncology.

Authors:  H J Biersack; B Briele; A L Hotze; P Oehr; L Qian; M A Mekkawy; W J Shih
Journal:  Ann Nucl Med       Date:  1992-08       Impact factor: 2.668

3.  Accumulation of thallium-201 in medullary thyroid cancer with negative serum calcitonin and carcinoembryonic antigens: a case report.

Authors:  M Koizumi; T Watari; K Hirabayashi
Journal:  Ann Nucl Med       Date:  1993-02       Impact factor: 2.668

4.  Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma.

Authors:  S Kosuda; H Yokoyama; M Katayama; T Yokokawa; S Kusano; O Yamamoto
Journal:  Eur J Nucl Med       Date:  1995-10

5.  Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation.

Authors:  S Dadparvar; A Chevres; M Tulchinsky; L Krishna-Badrinath; A S Khan; W J Slizofski
Journal:  Eur J Nucl Med       Date:  1995-11

6.  Scintigraphic detection of recurrence of medullary thyroid cancer.

Authors:  M Koizumi; Y Yamada; E Nomura; M Amano; Y Okajima; H Okizuka; K Yamada; S Sawano; T Kitahara; T Yamashita
Journal:  Ann Nucl Med       Date:  1995-05       Impact factor: 2.668

Review 7.  Imaging head and neck cancer using radioisotopes: a review.

Authors:  J C Watkinson; M N Maisey
Journal:  J R Soc Med       Date:  1988-11       Impact factor: 18.000

Review 8.  Depicting medullary thyroid cancer recurrence: the past and the future of nuclear medicine imaging.

Authors:  Evangelia Skoura
Journal:  Int J Endocrinol Metab       Date:  2013-10-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.